Virtonomy

Virtonomy’s virtual patient/digital twin technology enables rapid prototyping and regulatory validation of cardiovascular and other implantable medical devices. The company’s SaaS platform allows developers to simulate thousands of virtual patients using real clinical data. This approach accelerates time-to-market by reducing the need for animal/human trials and physical prototypes while supporting regulatory submissions with validated digital evidence. The technology has been adopted by leading medtech companies seeking faster approval pathways. No direct clinical trial results are reported since the company itself does not sponsor therapeutic trials.